As of January 22, 2025, Genenta Science (GNTA) has a market cap of $72.794 million USD. According to our data, Genenta Science is ranked No.7929 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $72.79 M |
-8.51%
|
Dec 31, 2024 | $79.56 M |
-12.12%
|
Dec 29, 2023 | $90.54 M |
-10.00%
|
Dec 30, 2022 | $0.10 B |
-49.83%
|
Dec 31, 2021 | $0.20 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
bluebird bio
BLUE
|
$77.02 M |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.82 B |
6.828 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.10 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.03 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.23 B |
-0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.00 B |
-0.030 B
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
-0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Cellectis
CLLS
|
$0.16 B |
4.583 M
|
France
|
Precision BioSciences
DTIL
|
$36.21 M |
-0.000 M
|
USA
|
Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.37 B |
0.000 M
|
USA
|
uniQure
QURE
|
$0.82 B |
-0.000 M
|
Netherlands
|
Market Cap | = | GNTA Stock Price | * | GNTA Shares Outstanding |
= | $3.98 | * | 18.29 M | |
= | $72.79 M |